July 26, 2011 — Concentric Medical Inc. has launched the DAC 070 Catheter, the fourth and largest diameter addition to ...
Stroke
This channel includes news and new technology innovations for stroke. It includes both diagnosis and treatment of stroke, stroke imaging, pharmaceuticals and interventional stroke technologies. Stroke comes in two forms, which have different therapies.
1. Ischemic stoke is a blockage of an artery in the brain, preventing blood flow and is offen referred to as a "brain attack" because it is a similar casue as a heart attack. This type of stroke is often treated with anti-coagulants, including use of tissue plasminogen activator (tPA). Interventional mechanical thrombectomy can also be used to remove the clot.
2. Hemorrhagic stroke is caused when there is bleeding due to a ruptured blood vessel in the brain caused by a brain aneurysm burst or a weakened blood vessels. These strokes are less common, but exact diagnosis is important, because use of tPA in these patients can have catastrophic consequences. Treatments include interventional embolization and surgical clipping of target vessels.
July 21, 2011 – Concentric Medical Inc. announced the launch of the expanded family of Merci Retrievers in Japan for the ...
May 23, 2011 -- Boston Scientific Corporation announced results from a clinical study evaluating the use of its Watchman ...
May 18, 2011 - Jasbir Sra, M.D., and Tanvir Bajwa, M.D., are the first in Wisconsin to implant a new device in a patient ...
March 28, 2011 – Patients who have suffered a "mini stroke" are at twice the risk of heart attack than the ...
March 11, 2011 – The U.S. Food and Drug Administration (FDA) has approved a surgical kit that allows ...
Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a ...
February 14, 2011 – Acute ischemic stroke hospitalizations among middle-aged and older men and women fell between ...
February 7, 2011 – A rare and often underreported form of stroke involving veins instead of arteries is more ...
December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to ...
December 29, 2010 – Patient enrollment has been completed for a Phase III trial of an oral Factor Xa inhibitor ...
November 16, 2010 – Results from the ROCKET AF trial showed that rivaroxaban given once daily is superior at ...
November 2, 2010 – Boston Scientific will sell its neurovascular business to Stryker for $1.5 billion in cash. Of ...
October 22, 2010 - Treating metabolic syndrome and undergoing carotid angioplasty may prevent recurrent stroke or ...
October 4, 2010 - Johnson and Johnson has completed the acquisition of Micrus Endovascular, a developer and ...